Monitoring the safety of medicines used off-label

G. J. Dal Pan

Research output: Contribution to journalArticlepeer-review

Abstract

Off-label use of medicines is common. Because many off-label uses have not been carefully studied, it is important that postmarketing drug safety systems be able to identify, assess, and monitor adverse events that occur in the off-label setting. The full range of postmarketing surveillance and analysis tools can be utilized to study the adverse effects of medicines used off-label.

Original languageEnglish (US)
Pages (from-to)787-795
Number of pages9
JournalClinical Pharmacology and Therapeutics
Volume91
Issue number5
DOIs
StatePublished - May 2012
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Monitoring the safety of medicines used off-label'. Together they form a unique fingerprint.

Cite this